Informed citizens are the foundation of good public health. Even the best healthcare systems and the best available treatments can’t create a healthy population unless individuals have strong health literacy themselves. That’s why accessible science is so crucial. But during moments of crisis, fear can grip whole populations at once. It’s in those environments that […]
Read more »
Because of the experimental nature of clinical research, legal questions arise quickly, especially for people who are thinking of joining a trial as a patient. Patients will want to know what legal protections they have against harm, for example. And as issues of personal data sovereignty continue to arise, patients will want to know […]
Read more »
Whether a generic or a branded competitor, a new drug’s entry into a market can be destabilizing for the incumbent — and the researchers who pioneered the treatment’s breakthroughs. But this is the nature of business. So, when a competitor emerges, it’s up to the incumbent company to prove the value of its treatment. […]
Read more »
PRESS RELEASE Randomization Simulator validates initial study design and accelerates adaptive study design changes TEMPE, ARIZONA, UNITED STATES, November 10, 2020 /EINPresswire.com/ — Anju Software has announced a powerful new patient Randomization Simulator, enabling statisticians at Pharma sponsors and CROs to analyze large numbers of alternative simulations to determine the best model for a clinical study’s results. […]
Read more »
In the early weeks of the novel coronavirus pandemic, the United Kingdom’s NHS organized a trial, called RECOVERY, that sought to identify and vet possible treatments for COVID-19. That trial explored everything from azithromycin to convalescent plasma drawn from recovering COVID-19 patients whose blood has antibodies. By June, the RECOVERY team had identified the […]
Read more »
The final day narrative of the inaugural Anju Innovation Forum was essentially “time is of the essence” combined with a new focus on adaptive and versatile data access and data interpretation solutions. Speed to data without sacrificing quality of data is absolutely critical for continuing to bringing the most promising future therapies to patients and their care providers. […]
Read more »
Customer Collaboration Drives Anju Future Product Innovations Day 2 of the Anju Innovation Forum provided a comprehensive look at all the new feature and functionality innovations for capturing, distributing and managing the explosion of different data sets and sources that Anju is incorporating into future releases across its clinical, medical affairs and database product offerings. Deep customer interest and engagement with […]
Read more »
Changing Data Demands Changing Face of Life Sciences If there was one message that came out of Day 1 of the first-ever Anju Innovation Forum it is this: 2020 is a year that changed the data capture and data management challenges of the life sciences industry and revealed the need for accelerated yet adaptive solutions – from […]
Read more »
In any pandemic, political narratives tend to emerge. Often, these narratives seek to assign blame to political enemies, or to deflect blame from those in power. That’s why the 1918 H1N1 flu was dubbed the “Spanish flu” and why some people have tried to get purchase with “China virus” in response to COVID-19. Other contexts […]
Read more »
Are you turning 50% of your data into actionable insights? This webinar will help you overcome the fear of the challenges related to data; allowing you to effectively analyze public data and make better, evidenced-based decisions. Many companies are having the same conversations regarding data and what to do with it because there is no […]
Read more »
Clinical Trial designs are becoming more complex and the pressure to streamline and accelerate clinical trials continues to increase. Nonetheless, it remains critical to carefully design randomization methods that will result in a final patient distribution that is optimized for statistical analyses. Please join Tony Warren, Anju Software’s Product Manager as he discusses how automated […]
Read more »
An increasingly connected world allows clinical researchers to expand their collaborations across borders and time zones. The ability to collaborate internationally on research and development has proven particularly useful in the search for a COVID-19 vaccine. Although international R&D collaboration offers opportunities, it also poses significant challenges. Balancing the national regulations of multiple countries […]
Read more »
The COVID-19 pandemic is affecting people’s mental health. In a July 2020 tracking poll conducted by the Kaiser Family Foundation (KFF), 53 percent of adults in the U.S. reported negative impacts on their mental health from anxieties caused by the global health crisis. That number was up from 32 percent in March, an indication that the longer […]
Read more »
PRESS RELEASE Link to EINPresswire Web portal adds secure, personalized self-service capability to industry gold standard IRMS Anju Software’s IRMS (Information Request Management System) has been the gold standard for Pharma Medical Information since 1995. During those decades, continual innovation propelled IRMS to remain the industry leader. The latest innovation further secures that position as Anju recently […]
Read more »
Clinical trials remain essential in order to understand the effects of medical developments on the conditions and patients they are intended to treat. Yet clinical trials remain out of reach for many patients. For example, a 2019 study by Joseph M. Unger and fellow researchers found that only 8.1 percent of cancer patients enrolled in a […]
Read more »
Medical affairs teams were already in a challenging position before the COVID-19 pandemic. Serving a growing number of stakeholders and co-leading products is a role that has only gained importance in the past years. The pandemic has made stakeholder engagement more difficult, but the need for MA’s co-leadership remains. With the right digital tools, […]
Read more »
Project management’s maturity as a discipline has had wide-reaching effects across most industries. It’s changed the way people manufacture products, develop software, plan company strategies — and even how clinical trials are conducted. Here, we explore how the evolution of project management has impacted clinical research, and what aspects of project management trial leaders […]
Read more »
TEMPE, September 24, 2020 – Anju Software, Inc. is pleased to announce that AnjuSafe, a new generation of enterprise content management (ECM) solution, is now certified for scalability by ZenQ, an internationally recognized independent testing group. AnjuSafe offers a content management platform specifically designed for the Life Science industry. Unlike older technology ECM products, the […]
Read more »
The modern world has been built on a simple premise, that science gives us the best lens for viewing and understanding reality. Faith in that lens waxes and wanes, though, as Sabrina Sholts, Ph.D. at the Smithsonian Institution’s National Museum of Natural History writes. Sholts cites Carl Sagan’s “Demon Haunted World,” written during a moment in […]
Read more »
The coronavirus pandemic has thrust pharmaceutical companies into the spotlight. As a result, medical affairs professionals are more visible and important than ever. Creating and disseminating accurate information is essential. So is staying abreast of the latest and developments and trends. Conferences and events offer the perfect opportunity for medical affairs professionals to learn […]
Read more »
Staying on top of industry innovations and trends in the ever-changing clinical trials industry is mandatory for professionals in contract research organizations. We’ve compiled a list of the top global conferences for the rest of 2020 that CRO practitioners can attend to further their professional development, partnerships and networking opportunities. BioTech Week Boston Virtual Conference […]
Read more »
Feng Cheng, Anju Software I Senior Vice President of Business Development, APAC presents eSource Strategies in Clinical Trials at dTrial Forum in Nanjing, China on September 4. In this session, Feng explains how the use of information technology to manage clinical research processes and data is a necessary requirement. Not attending but want to learn […]
Read more »
Clinical trial research has both inherent limitations and constraints imposed by regulations. Data is at the heart of those limitations. In some cases, the data needed to test a hypothesis might simply not exist, or be insufficient. In other cases, access to crucial data could compromise a patient’s privacy. A potential workaround to these […]
Read more »
Even in the best of times, the medical affairs team has a hefty workload. During a pandemic, however, when professional interactions are mediated by digital connections and social distancing requirements, Medical Science Liaisons (MSLs) face a significantly higher degree of difficulty. It’s harder to build and maintain crucial stakeholder relationships when personal bandwidth is maxed […]
Read more »
The COVID-19 pandemic is affecting every aspect of life and business, but few fields have to gird for its long-term impacts as clinical research does. The novel coronavirus outbreak has disrupted months of clinical trial data, wreaked havoc on research budgets, and revealed some things that will need to change in the designs and […]
Read more »
No therapies or pharmaceuticals get made in a vacuum. Each drug, each treatment is developed with a specific purpose in mind, whether that is to treat a symptom or completely cure a condition. Those drugs are tested, they are brought to market, and their impacts on patient outcomes are studied. Those outcomes inform subsequent […]
Read more »
Clinical research teams are no strangers to pressure. Even still, conducting trials and performing potentially life-saving research during a pandemic makes the work that much harder. Resources need thoughtful management, recruitment becomes more complicated and collective medical knowledge changes daily. Below are some of the ways clinical research directors can ensure their teams have […]
Read more »
The COVID-19 pandemic has set off a flurry of medical research — not the least of which is the ongoing search for a vaccine. Other important lines of investigation are happening at the same time, though. Researchers are trying to find effective treatments and trying to understand how COVID-19 outcomes might be affected by […]
Read more »
Participants in clinical trials juggle their own responsibilities and obligations. Just as their motivations for participating in clinical trials are various, so are the sacrifices they make to accommodate the trial. Further, clinical trials can take social and emotional tolls on participants. Depending on the nature of a given trial, reimbursement alone might not provide participants […]
Read more »
Patient medical literacy remains a challenge for healthcare providers and pharmacists. Certainly, many people are turning to the internet to inform themselves about conditions and potential treatments, but many other patients struggle with things like treatment adherence when the directions that come with a prescription drug appear incomprehensible. The solution, then, is for packaging, drug labeling […]
Read more »
Each year, scores of clinical trials are delayed because participant recruitment proves more difficult than trial directors imagined. That’s why trial recruitment teams put considerable energy into communicating their studies to relevant demographics. In many cases, additional incentives are offered to recruit people who might not have participated otherwise. This is an effective way […]
Read more »
Natera selects PUBSTRAT as its enterprise scientific publication management solution. TEMPE, AZ, June 17, 2020, Anju Software, Inc. enthusiastically welcomes Natera as another member to its ever-expanding PUBSTRAT Partner Community. Natera, a San Carlos, CA-based organization is a rapidly growing diagnostics company with proprietary bioinformatics and molecular technology for analyzing DNA. Natera offers eight molecular […]
Read more »
Just as care and rigorous testing are crucial for the early stages of a drug’s life cycle, vigilance and real-world data gathering are crucial for the late stages of a drug’s life cycle. Drug manufacturers must keep track of patient outcomes, respond to inquiries about off-label use, remain aware of market realities and keep […]
Read more »
Concerns about fake news have not escaped the fields of pharmacology or clinical trials. Far from it, in fact. The COVID-19 pandemic has revealed just how easily pseudoscience and bad medical advice can spread. Against this backdrop of medical misinformation, however, are teams of researchers working around the clock to test new therapies, to […]
Read more »
The healthcare journey of cancer patients can be overwhelming, tumultuous and intimidating. Nurse navigators can help to ease patients’ worries, supporting them and their families by providing care and comfort, while educating and informing them about the disease. Here we look at the role of nurse navigators in oncology trials. What The Nurse Navigator […]
Read more »
By Cindy Botha | Product/UI Designer, Data Division We are living in a world of quickly evolving technology. Analytical software for life sciences with poorly designed user interfaces can result in unproductive research and can be time-consuming, tedious, and frustrating. UX (user experience) design holds great potential for scientific software that handles big data. Imagine […]
Read more »
COVID-19 is wreaking havoc on a global scale. Infections continue to spread rapidly as the death toll rises. The World Health Organization, national governments and pharmaceutical companies are strategizing on how to deliver a vaccine with speed and efficiency. Now, more than ever, medical affairs teams can play an impactful role in disseminating scientific […]
Read more »
Today’s New Normal There is no getting around the “new normal.” The impact of COVID-19 can be felt across businesses in every corner of the globe. New processes and procedures. Adjustments to just about every aspect of doing business during this disruption. Even the life science industry was not spared. Many clinical trials have been […]
Read more »
Clinical trials for cancer treatments make up the majority of global clinical trials — both industry (20.5 percent) and non-industry sponsored (11.3 percent). The data from GlobalData also shows that the U.S. is the leader in terms of the number of planned trials to be initiated in 2020. Indeed, the U.S.-based trials are almost equal to […]
Read more »
Clinical trials can further medical science and give patients vital treatment to improve their lives. Yet the general public’s awareness of clinical trials remains low. One way to improve awareness of clinical trials is for pharma to align with patient advocacy groups and other disease awareness campaigners to spread messaging to patients. Here we look at […]
Read more »
The fast-evolving nature of the COVID-19 pandemic has caused major challenges and posed unprecedented risks to global health. To this end, thousands of scientists around the globe have joined forces and are doing their utmost to find reliable interventions that can help in controlling the outbreak. This matter can be seen in the public clinical […]
Read more »
Patient-centricity is the watchword in clinical research and healthcare more generally. Putting patients first not only improves the quality of their participation — which is good for clinical trial recruitment and retention — but also helps shape the design and protocol of trials. Medical affairs teams are increasingly seen as the conduit between pharma and patients, and indeed […]
Read more »
Anju Software recently attended and exhibited at the ISMPP EU 2020. The meeting theme, Precision Communication: Achieving Clarity, Reach and Value reflects ISMPP’s expanded mission and vision to include all aspects of scientific communications and highlights the increasing need for personalization of communications to ensure the needs of all stakeholders are met in a world where medicine […]
Read more »
The pharma industry, along with healthcare more generally, is pursuing value-based healthcare (VBHC). This is promising news for all stakeholders: Payers invest in treatments that provide better patient care; healthcare providers are no longer motivated by fees for service; and patients are at the centre of the clinical experience. But VBHC requires careful coordination […]
Read more »
We’ve written before about the perennial problem with recruitment and retention of clinical trial patients. Naturally, clinical trial managers and sponsors want to find effective ways to engage patients. Social media is an obvious method to facilitate this engagement. Here we look at some of the risks and opportunities going social can deliver and how best to […]
Read more »
Semantically linking public and private data records using groundbreaking technology creates a value proposition that can’t be ignored. TEMPE, AZ, UNITED STATES, May 12, 2020 /EINPresswire.com/ — Anju Software announces a revolutionized array of data integration, curation and visualization solutions for the pharmaceutical industry using its new Anju Data Platform (ADP) back-end to the company’s clinical intelligence product, ta-Scan. Anju’s […]
Read more »
Creating a publications project workflow and management system that offers a greater value for Agencies and their clients TEMPE, AZ May 5, 2020 – Anju Software is teaming up with agencies through its PUBSTRAT Software Suite to elevate the value that agencies can offer their clients. PUBSTRAT is a leading web-based publication planning system purpose […]
Read more »
The medical affairs function is fast becoming a strategic lynchpin in pharmaceutical company’s business strategy. The value MA brings is that it straddles the divide between the commercial and research arms of pharma organizations. The messaging it communicates to both internal and external stakeholders is grounded in hard science but uses relatable language. With […]
Read more »
In a bid to ease the burden on patients and boost the notoriously low levels of recruitment and retention in clinical trials, sponsors are turning towards virtual clinical trials. The shift in direction has also meant that CROs have had to look for ways to adapt to new market demands. Here we look at the […]
Read more »
Although there is still much debate about what defines a predatory publication or meeting, there can be no doubt that the prevalence of such questionable outlets jeopardize the integrity of our profession and the potential impact the science we work tirelessly to communicate. A recent article published in Nature classified predatory journals as a “global threat.”1 While in […]
Read more »
Across the globe, only regulators in the U.S. and New Zealand permit pharma organizations to use direct-to-consumer advertising to sell prescription medications. It wasn’t always this way. DTC advertising for prescription drugs in the U.S. was only legalized in 1997 after successful lobbying by big pharma, explains healthcare consultant Reenita Das. And during the past two decades, […]
Read more »
In clinical research, patient attrition, losing patients to follow-up, especially in longitudinal studies, leads to missing crucial outcome data, impacting study integrity. Proactive measures to retain participants are vital to maintain data completeness, ensuring reliable conclusions in clinical trials, where recruitment and retention pose ongoing challenges. In this post, we explore the most common reasons […]
Read more »
Currently, over a third of the world’s population is under lockdown due to a novel coronavirus (COVID-19). The virus, causing respiratory and flu-like symptoms, emerged in late 2019 in the Chinese city of Wuhan. The disease is already considered a pandemic due to the rapid spread across six continents. In response, researchers are focusing on finding a […]
Read more »
By Bridget Tyrka, MS, CCRC, PMP Perceived and actual barriers to clinical trial patient engagement have been a show-stopping conundrum that researchers and recruiters have struggled with for decades, leading to 80% of all clinical trials failing due to low recruitment rates (Jahdiv, 2016). Currently, with the rapid proliferation of COVID-19 and resulting shelter–in-place orders (a very real […]
Read more »
Medical information is everywhere. Consumers have unprecedented access to healthcare information regarding diseases, conditions, and therapeutics, from search engines to social media hubs to dedicated websites like WebMD. However, not all information is created equal. Misinformation abounds, and pharmaceutical companies need dedicated tools to communicate directly with healthcare providers (HCPs) and consumers to ensure that […]
Read more »
Tempe, AZ, April 3, 2020 – Disparate data sources, variations in data formats, and resource-intensive cleansing and mapping requirements have historically posed significant challenges to pharmaceutical and healthcare organizations. In response, Anju Software, Inc. announces the first-of-its-kind Big Data Management Platform, purpose-built for life sciences, that enables the full automation and transformation of raw data into […]
Read more »
It’s a well-established fact that clinical trials are challenging. They are expensive and suffer from multiple difficulties such as patient recruitment and retention, unexpected changes to protocol and trial design issues. We explore some of the major pitfalls that beset sponsors and research professionals when designing clinical trials, and also take a look at how […]
Read more »
Patients commit to clinical trials for multiple reasons. However, a prevalent cause is to further medical science — they want to know that their participation has been valuable. Clinical trial data sharing is an important means of showing patients this value but it remains a complicated issue in clinical research. We explore how data sharing can […]
Read more »
We are inspired by you, our clients who are devoted to the pursuit of disease treatment and prevention. It is through your efforts that we remain confident for a positive outcome despite these unprecedented times. As the uncertainty of COVID-19 continues, we want to assure you that we are here to help you in every […]
Read more »
Patients are increasingly engaged in their own healthcare. They have access to research, community forums and patient advocacy groups. They feel more empowered to take control of their own health. This makes direct-to-patient trials an obvious choice for certain trials. But other than meeting patients’ changing needs and wants, DTP trials can also simplify and […]
Read more »
Research experts know that some degree of systemic bias is inherent to clinical trials. It’s naive to think that any trail could be 100 percent free from it. In clinical trials, the question really isn’t about whether bias is present or not, but rather the degree to which bias is prevented. Proper study design and implementation help […]
Read more »
Professionals working at contract research organizations need to keep abreast of an evolving marketplace, finding new ways to expand their offerings, digitize their processes and maximize data. Consequently, learning and professional development remain an ongoing activity for clinical research practitioners. One way to keep learning is to attend relevant industry conferences. Here’s our pick of the top global […]
Read more »
Medical affairs teams are becoming increasingly important to the developments of pharma companies. They are key to disseminating relevant and factual medical information to physicians and to patients who wish to be more engaged in their healthcare journey. The medical affairs is evolving and there is much to learn from and share with fellow industry professionals, which […]
Read more »
Insights from 2020 European Meeting of ISMPP- Precision Communication: Achieving Clarity, Reach and Value Anju Software recently attended and exhibited at the ISMPP EU 2020. The meeting theme, Precision Communication: Achieving Clarity, Reach and Value, reflects ISMPP’s expanded mission and vision to include all aspects of scientific communications and highlights the increasing need for personalization of communications to […]
Read more »
February 18-21, 2020 | Orlando, FL Anju Software offers multiple products and services over the clinical development space. In February, Anju will showcase its entire suite of eClinical Software Solutions: ta-Scan, TrialMaster, TrialOne, IRTMaster, AutoEncoder, Acuity Analytics, and ClinPlus. As Anju, we have combined our clinical ops and clinical trials product offerings and look forward to showing our end-to-end services. Curious how we can help […]
Read more »
Global clinical trials present several opportunities to sponsors. Broader population pools and lower operational costs are two significant drivers behind a multinational approach to research. Indeed, many emerging markets have significant potential for sponsors. But managing patients in multiple parts of the world can be challenging when it comes to compliance. We explore the growth in global clinical trials […]
Read more »
Clinical trials function more efficiently and produce better results when patients are engaged in the process. Increasingly, the industry is moving towards a patient-centric approach to clinical research and the design of trials. Reducing patient burden is a big part of this as it helps to boost recruitment and retention rates. But there is also value in […]
Read more »
January 21-22, 2020 | London, UK Anju’s Publication Planning team will showcase their services at the ISMPP European Meeting 2020. Stop by for a live showcase of the PUBSTRAT Suite – Publication Project Management Application. Ask our team about new Abstract Library! Visit us in the exhibition area or make an appointment with Kelly Malloy, Vice President, Product Strategy- […]
Read more »
There has been a significant shift in the clinical research industry towards delivering an enhanced patient experience. The underlying premise is to put the patient first and the design of studies and delivery of treatment will follow. “Patient experience is the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across […]
Read more »
Off-label drugs present many treatment opportunities. They can be used to treat conditions or given in dosages that the FDA has not yet approved. This means that doctors can prescribe them but pharmaceutical companies are not allowed to market them to the public. To get these drugs then to patients to help treat their conditions, […]
Read more »
Virtual reality devices present new possibilities in clinical trials. From helping patients to manage anxiety and pain to providing key training for researchers, VR has big potential. Studies using VR devices are growing in number and, so far, the results are heartening. In this post, we explore how virtual reality is being used in clinical […]
Read more »
The medical affairs team of a pharmaceutical organization is tasked with significant responsibilities. It’s the conduit between the company and external stakeholders, physicians and patients. It has to communicate complex information clearly. Medical information letters are a good example of this challenging role. When a pharma organization receives an unsolicited call for information about an […]
Read more »
Insights from DIA 2019 Medical Information and Communications Conference – Lisbon, Portugal Anju Software recently attended and exhibited at the DIA 2019 Medical Information and Communications Conference in Lisbon, Portugal, highlighting IRMS Software Platform and OpenQ. This forum is designed for medical affairs professionals, by medical affairs professionals. It provides a comprehensive understanding of the regulatory and compliance environment […]
Read more »
Finding cures for lifelong illness is arguably the core motivating factor for clinical research professionals. Unfortunately, it’s seldom the reality. More realistically, researchers are hoping to develop a treatment that can improve the quality of the patient’s life by reducing the symptoms or slowing the progression of the disease. In this post, we explore some of the […]
Read more »
FORT LAUDERDALE, Fla., Dec. 02, 2019 (GLOBE NEWSWIRE) — FGK Clinical Research GmbH (FGK), a European, full-service contract research organization has entered into a multi-year partnership with OmniComm Systems, Inc., an Anju Software company and a leading global provider of patient-centric, clinical data management technology. Under the terms of the agreement, FGK will use TrialMaster® […]
Read more »
OmniComm’s IRTMaster Features Configurable, Pre-Validated Modules to Accelerate Trial Development FORT LAUDERDALE, Fla., Nov. 25, 2019 (GLOBE NEWSWIRE) — OmniComm Systems, Inc., an Anju Software Company and leading strategic software solutions provider to the life sciences industry, announced today its release of IRTMaster Version 5.2, an enhanced product offering to complement their comprehensive eClinical suite. […]
Read more »
Changing Tides and Technology in Scientific Communications 14-15 Nov 2019 By Rachel Sheldon | Customer Success Manager, Medical Affairs Division Recently, Anju Software sponsored, exhibited and attended the ISMPP West 2019 meeting in San Diego, California. Kelly Malloy, Director of Business Development and I were both in attendance at the conference. ISMPP West is a wonderful complement to the larger […]
Read more »
Historically, clinical trials have stuck rigidly to formal phases. Phase I trials test new drugs or devices with small groups of people. Phase II trials study larger populations and implement placebo groups. Phase III trials study even larger populations and can be used to seek FDA approval. Phase IV follows approval and to establish the […]
Read more »
As the proven leader in medical information management systems, we recognize how important it is that MI departments utilize the best technology available to meet their dynamic demands for medical information. Our Medical Information system allows you to easily capture requests for medical information, adverse events, and product complaints and quickly respond to those requests […]
Read more »
After a pharma company or its supplier receives a routine inspection from an FDA inspector, they will receive an FDA Form-483, usually referred to as a 483. Depending on how many observations are made by the inspector — and the severity of those observations — this report could have serious consequences for the pharma companies […]
Read more »
Anju’s Publication Planning team will showcase their services at the ISMPP West 2019 Meeting. Stop by for a live showcase of the PUBSTRAT Suite – Publication Project Management Application. Ask our team about Online Collaborative Editing Capabilities, Digital Onboarding, Data Visualization/Publication Intelligence Tools and Integration with all major Medical Affairs platforms. Visit us in the exhibition area […]
Read more »
More than three years have passed since Brexit, the referendum in which the UK voted to leave the European Union. Since then, the country has been through two prime ministers and missed the first Brexit deadline. With Boris Johnson now leading the country towards the new exit deadline of October 31, 2019, the UK is […]
Read more »
PRESS RELEASE Built on NOSQL DB, Safe can be implemented as a standalone ECM solution or as an upgrade to Anju’s IRMS Web or eClinical Suite PHOENIX, ARIZONA, UNITED STATES, October 28, 2019 /EINPresswire.com/ — Anju Safe ECM is an Enterprise Content Management (ECM) solution using NOSQL DB that can store structured and unstructured data, images and […]
Read more »
The rise in data analytics, electronic health records and an increased focus on patient-centricity is driving change in clinical trial operations. As a result, the relationships between stakeholders within the clinical trial ecosystem is changing too. Key within this paradigm shift is a move towards greater collaboration and data sharing. In this post, we explore what these […]
Read more »
Automation of data exchange and, more broadly, clinical trial processes, present the clinical research industry with myriad possibilities. Streamlined trial management, improved data collection, analysis and sharing, better matching of eligible patients with trials — and an overall enhanced experience for all stakeholders — are areas of success achieved with the promise of more. As […]
Read more »
Treating clinical research as a viable healthcare option presents benefits to patients, physicians and the broader research community. This approach helps to foster more patient-centric studies and increases the diversity of patients that have access to clinical trials. In this post, we look at what clinical research as a care option (CRAACO) entails and how […]
Read more »
Patients expect their healthcare providers to be knowledgeable and informative. But they also want them to be supportive, attentive and comforting. Research shows that patients who receive treatment from HCPs with effective bedside manners respond better to treatment and are more likely to follow doctors’ orders. Part of this bedside manner requires that HCPs treat […]
Read more »
Depending on who you ask, the first informal clinical trial might be traceable all the way back to biblical times, during which a king monitored the effects of different diets on his subjects. While the essential ethos of today’s studies remains the same as the king’s trial, the methodologies, efficiencies, technologies and scale have transformed […]
Read more »
Insights from the CBI’s 15th Annual Medical Publications and Communications Forum which is one of the life science industry’s leading events in medical communications with a focus on publications. 10-12 Sept 2019 by Kelly Malloy | business development director, medical affairs division Recently, Anju Software sponsored and attended CBI’s 15th Annual Medical Publications and Communications Forum in Philadelphia. […]
Read more »
September 23-25, 2019 | San Diego, CA As a sponsor of the Medical Affairs Strategic Summit, Anju Software has a comprehensive understanding of the unique requirements of Medical Affairs, enabling us to effectively deliver solutions to our clients. Kelly Malloy, our PUBSTRAT expert and Steven Anzuini, IRMS and OpenQ specialist, will be at our booth and available to schedule a meeting and demo […]
Read more »
Phoenix, Arizona, September 18, 2019 – Anju Software Inc. has completed the acquisition of OmniComm Systems, Inc. (OTCQX: OMCM), a leading strategic software solutions provider to the life sciences industry. Under the terms of the agreement, OmniComm is now a wholly owned subsidiary of Anju, a provider of data, software and services to life science […]
Read more »
The global contract research organization services market is set to reach $90,926.3 million in 2026, up from $38,396.4 million in 2018, exhibiting a compound annual growth rate of 9.9 percent, according to Fortune Business Insights. It’s clear that outsourcing clinical trials continues among sponsor organizations. Still, that doesn’t mean there isn’t room for improvement — according to outgoing […]
Read more »
September 23-24, 2019 | Long Branch, NJ This year’s theme is “Technology for Life: Inspiring Innovation for Sustainable Impact”. Anju Software adds value to the Life Sciences Industry through global reach and our ethos of continuous product improvement. Anju is proud to be part of the 23rd Merck Technology Symposium. Reed McLaughlin, Vice President of Sales will be there […]
Read more »
Anju Software is pleased to be attending DIA’s Global Clinical Trial Disclosure and Data Transparency Conference. Kelly Malloy, our Disclosure expert, will be in attendance and available to schedule a meeting to discuss your needs. To reach Kelly and schedule some time, please email her here. About DIA’s Global Clinical Trial Disclosure and Data Transparency Conference Clinical trial information […]
Read more »
As-is analysis is closely aligned with to-be analysis. The former helps an organization assess where it’s currently at, while the latter gives them a future point to reach. Businesses see the value in this type of continual improvement analysis as it allows them to determine what operational and administrative functions perform well and which to […]
Read more »
Anju Software is pleased to be sponsoring and attending the 15th Annual Medical Publications and Communications Forum. Kelly Malloy, our PUBSTRAT expert, will be in attendance and available to schedule a meeting and demo showcasing the latest updates for PUBSTRAT. To reach Kelly and schedule some time, please email her here. About CBI’s Annual Medical Publications and Communications Forum […]
Read more »
Clinical directors don’t have it easy. While the number of contract research organizations has boomed in recent years — and growth isn’t slowing — there aren’t enough clinical research associates (CRAs) to go around. The contract research organization (CRO) market is set to increase by between 7.4 and 8.2 percent annually until 2023; however, the […]
Read more »
Primary care physicians and other healthcare providers are valuable links between clinical researchers and patients. So sponsors should support them and provide tools and resources to access information about clinical trials. But not all patients have access to a primary care doctor. And demographic factors such as age and socio-economic background tend to affect this. […]
Read more »
Electronic health records (EHRs) aren’t simply paper-based files copied to computers. They are shared systems of medical records that give clinical researchers access to vast amounts of patient data. This puts a larger patient populations within their reach. It also allows researchers to better match patient eligibility with research areas, thus advancing the development of precision medicine. […]
Read more »